Severe COVID-19: NLRP3 Inflammasome Dysregulated

Frontiers in Immunology
Daan F van den Berg, Anje A Te Velde

Abstract

SARS-CoV-2 might directly activate NLRP3 inflammasome resulting in an endogenous adjuvant activity necessary to mount a proper adaptive immune response against the virus. Heterogeneous response of COVID-19 patients could be attributed to differences in not being able to properly downregulate NLRP3 inflammasome activation. This relates to the fitness of the immune system of the individual challenged by the virus. Patients with a reduced immune fitness can demonstrate a dysregulated NLRP3 inflammasome activity resulting in severe COVID-19 with tissue damage and a cytokine storm. We sketch the outlines of five possible scenarios for COVID-19 in medical practice and provide potential treatment options targeting dysregulated endogenous adjuvant activity in severe COVID-19 patients.

References

Jul 10, 1999·Science·H WangK J Tracey
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·H WangK J Tracey
Aug 25, 2004·Medical Hypotheses·Guoqian ChenHaichao Wang
Mar 24, 2006·Viral Immunology·Haichao WangWei Li
Oct 28, 2008·Experimental and Molecular Pathology·Yingkai FengYousheng Liu
Apr 29, 2009·The International Journal of Biochemistry & Cell Biology·Chak-Ming ChanHo Yin Edwin Chan
Jan 12, 2011·Annual Review of Immunology·Ulf Andersson, Kevin J Tracey
May 3, 2013·American Journal of Physiology. Cell Physiology·Jutaro FukumotoNarasaiah Kolliputi
May 28, 2013·Biochemical Pharmacology·Minghua YangDaolin Tang
Jul 23, 2014·Yonsei Medical Journal·Shin-Ae LeeJeon-Soo Shin
Feb 3, 2015·American Journal of Physical Anthropology·Eric C Shattuck, Michael P Muehlenbein
Mar 15, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sung-Soo JungKiichi Nakahira
Jun 13, 2015·Critical Care : the Official Journal of the Critical Care Forum·Nobuyuki NosakaTsuneo Morishima
Oct 1, 2015·Journal of Medicinal Chemistry·Alex G BaldwinSally Freeman
Nov 26, 2015·Frontiers in Pharmacology·Bo-Zong ShaoChong Liu
Aug 16, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J PrimianoJ Perry Hall
Dec 8, 2016·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yu JiaGang Chen
Dec 27, 2016·Frontiers in Immunology·Anje A Te VeldeIrma Joosten
Jan 1, 2017·Journal of Cellular and Molecular Medicine·Junying DingQingquan Liu
Jul 27, 2017·European Journal of Immunology·Yilong ZhouBaoxue Ge
Aug 3, 2017·Metabolism: Clinical and Experimental·Jakeline RheinheimerDaisy Crispim
Oct 13, 2017·Journal of Molecular Biology·Mohanalaxmi IndramohanAndrea Dorfleutner
Feb 16, 2018·Expert Opinion on Therapeutic Targets·Ulf AnderssonHelena Harris
Mar 14, 2018·EMBO Molecular Medicine·Yi HuangRongbin Zhou
Apr 13, 2018·Frontiers in Physiology·Eun Jung KimChi Dae Kim
Jun 7, 2018·European Journal of Clinical Investigation·Roland ImmlerMarkus Sperandio
Aug 10, 2018·Ecotoxicology and Environmental Safety·Runxiao ZhengHaiyuan Zhang
Oct 1, 2018·Seminars in Immunology·Eicke Latz, Peter Duewell
Oct 31, 2018·Proceedings of the National Academy of Sciences of the United States of America·Marten SchefferMarcel G M Olde Rikkert
Feb 15, 2019·Frontiers in Microbiology·I-Yin ChenTakeshi Ichinohe

❮ Previous
Next ❯

Citations

Oct 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Christina F SandallJustin A MacDonald
Oct 20, 2020·Frontiers in Immunology·Alessandro StellaPiero Portincasa
Nov 26, 2020·Clinical Reviews in Allergy & Immunology·Chin-An Yang, Bor-Luen Chiang
Jan 7, 2021·Free Radical Research·Hung-Chi YangDaniel Tsun-Yee Chiu
Jan 9, 2021·International Immunopharmacology·Nadia Alice Vieira MottaFernanda Carla Ferreira de Brito
Dec 9, 2020·International Immunopharmacology·Luiz Henrique Agra Cavalcante-SilvaSandra Rodrigues-Mascarenhas
Oct 9, 2020·Multiple Sclerosis and Related Disorders·Arianna Di StadioEvanthia Bernitsas
Oct 26, 2020·Basic & Clinical Pharmacology & Toxicology·Ali Saeedi-BoroujeniArash Alghasi
Feb 9, 2021·Frontiers in Medicine·Ya Liu, Hai-Gang Zhang
Feb 16, 2021·Frontiers in Physiology·Juliana Carvalho SantosAlessandra Gambero
Feb 11, 2021·International Journal of Molecular Sciences·Sarah Seeherman, Yuichiro J Suzuki
Nov 17, 2020·British Journal of Anaesthesia·Amit JainD John Doyle
Mar 2, 2021·Frontiers in Cellular and Infection Microbiology·Shamila D AlipoorIan M Adcock
Mar 12, 2021·Expert Opinion on Pharmacotherapy·Juan Luis Gomez Marti, Adam M Brufsky
Mar 16, 2021·Frontiers in Immunology·Dominique MoserTobias Woehrle
Mar 20, 2021·Frontiers in Cellular Neuroscience·Elisa Gonçalves de AndradeMarie-Ève Tremblay
Mar 26, 2021·Frontiers in Pharmacology·Benedicto Crespo-FacorroJesus Sainz
Apr 30, 2021·Frontiers in Immunology·Jintao ZhangWei Zhao
May 1, 2021·Pharmaceutics·Matteo PuccettiStefano Giovagnoli
May 8, 2021·Frontiers in Pharmacology·Vikas P SukhatmeVidula V Sukhatme
May 11, 2021·Frontiers in Pharmacology·Hayder M Al-KuraishyGaber El-Saber Batiha
May 21, 2021·Frontiers in Pharmacology·Akash SaggamBhushan Patwardhan
May 22, 2021·Immunopharmacology and Immunotoxicology·Ali Saeedi-BoroujeniAli Khodadadi
May 26, 2021·Rheumatology International·Zafer GünendiŞebnem Ataman
Jun 8, 2021·Zeitschrift für Rheumatologie·Z BoyadzhievaM Krusche
Jun 8, 2021·Frontiers in Immunology·Giovanni A RossiPaola Mastromarino
Jun 12, 2021·Journal of Clinical Immunology·Lina M Castano-JaramilloSaul O Lugo Reyes
Jun 22, 2021·Progress in Cardiovascular Diseases·Ross ArenaUNKNOWN HL-PIVOT Network
Jun 29, 2021·Advanced Drug Delivery Reviews·Danielle BrainNeill J Liptrott
Jun 22, 2021·Frontiers in Molecular Biosciences·Hongliang ZhangJinhui Tao
Jul 1, 2021·Oxford Open Immunology·Clarissa CoveneyUNKNOWN Oxford-Cardiff COVID19 Literature Consortium
Jul 24, 2021·Molecular Biology Reports·K A DvornikovaA Lerner
Jul 9, 2021·Signal Transduction and Targeted Therapy·Lan YangYufeng Zhou
Jul 29, 2021·Molecular and Cellular Biochemistry·Hayder M Al-KuraishyGaber El-Saber Batiha
Aug 20, 2021·Frontiers in Immunology·Qinzhi YangMao Luo
Aug 17, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Neha DabholkarGautam Singhvi
Sep 10, 2021·Neurology. Neuroimmunology and Neuroinflammation·Martin S WeberMichael R Yeaman
Oct 3, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Erin CloughSupriya D Mahajan

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.